Suppliers / Laboratorio Italiano Biochimico Farmaceutico Lisapharma

Laboratorio Italiano Biochimico Farmaceutico Lisapharma

Italy 33 employees Updated 9 July 2026

Laboratorio Italiano Biochimico Farmaceutico Lisapharma is a finished-dose manufacturer based in Italy. It appears in 56 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with AIFA (IT), EMA and ANPP (DZ). Its GMP standing is certified by EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 26 January 2024 as VAI.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
56
filings across 7 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 26 January 2024 VAI US FDA
  • 26 September 2023 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
22036- Erba (Co), United Arab Emirates Not on file
Erba, Italy Not on file
Italy, Italy 3008477458

Filings and GMP by regulator

Regulator Filings GMP certificates
AIFA (IT) 29 None
EMA 11 2
ANPP (DZ) 8 None
EDE (AE) 5 None
UZPHARM (UZ) 1 None
NMPA (CN) 1 None
US FDA None 1

Questions about Laboratorio Italiano Biochimico Farmaceutico Lisapharma

Does Laboratorio Italiano Biochimico Farmaceutico Lisapharma hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Laboratorio Italiano Biochimico Farmaceutico Lisapharma. It does have 56 filings with 7 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Laboratorio Italiano Biochimico Farmaceutico Lisapharma FDA-registered?
One site operated by Laboratorio Italiano Biochimico Farmaceutico Lisapharma carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Laboratorio Italiano Biochimico Farmaceutico Lisapharma's last inspection go?
The most recent inspection on record closed on 26 January 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 2 inspections are on file.
Where does Laboratorio Italiano Biochimico Farmaceutico Lisapharma manufacture?
3 registered sites are on record, in United Arab Emirates and Italy (22036- Erba (co), Erba and Italy). Every site is listed on this page with the register it came from.
Which regulators recognise Laboratorio Italiano Biochimico Farmaceutico Lisapharma's GMP?
Current GMP certificates are on record from EMA and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Laboratorio Italiano Biochimico Farmaceutico Lisapharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 26 January 2024.

Comparable suppliers

A. Menarini Manufacturing Logistics And Services also in Italy Adienne also in Italy AlfaSigma also in Italy Aptuit also in Italy Avara Liscate Pharmaceutical Services also in Italy

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates